GlaxoSmithKline launches satellite R&D teams in search of new products

Just like NASA sends satellites to explore for new discoveries in outer space, drugmaker GlaxoSmithKline ($GSK) is sending R&D folks into new areas to look for drugs. The U.K.-based company is launching satellite innovation centers in Cambridge, MA, and San Diego, with the idea that they can mentor research partnerships while hunting down new technologies and starting biotech startups. The office in San Diego will be overseen by Damien McDevitt and include an R&D team of 5 to 10 staffers. It is the company's first R&D office in California. Story | More

Suggested Articles

UnitedHealthcare will stop covering Descovy in PrEP in favor of Truvada, which is on track to see low-cost generic competition in September.

AstraZeneca has signed into the EU’s first finalized COVID-19 vaccine supply agreement.  

The U.K.'s two new deals with J&J and Novavax bring its stockpile of potential COVID-19 vaccines to 340 million doses while expanding clinical trials.